title: Comparative pharmacological studies on the A2 adenosine receptor agonist 5'-n-ethyl-carboxamidoadenosine and its F19 isotope labelled derivative.
abstract: Adenosine receptors are expressed in various mammalian tissues where they mediate the effects of adenosine on cellular functions through a number of signalling mechanisms. 18F-NECA is the positron-emitting derivative of the A(2)-receptor agonist NECA (5'-n-ethyl-carboxamidoadenosine) and is a radioligand for PET imaging of adenosine receptors. Contractility and relaxation studies were performed on guinea pig atrial myocardium, pulmonary artery, and thoracic aorta to compare the pharmacological effects of NECA and F-NECA (a non-emitting derivative) on tissues. Furthermore, the effect of NECA and F-NECA on the potassium conductance was investigated in DDT1 MF-2 smooth muscle cells with the patch-clamp technique. Both NECA and F-NECA reduced the contractile force in atrial myocardium and evoked phasic contraction in pulmonary artery (A(1) adenosine-receptor-mediated actions) in a dose dependent manner; however, the apparent affinity was lower for F-NECA. No difference was found in relaxation induced by these compounds in 1 microM noradrenaline-precontracted aorta and pulmonary artery (in the presence of DPCPX, an A(1) adenosine receptor antagonist, tissue containing A(2B) adenosine receptors). NECA (5 microM) and F-NECA (5 microM) also decreased the peak current and accelerated activation and inactivation properties of the potassium channels, but F-NECA was less effective. These results suggest that while NECA and F-NECA are equivalent agonists of vascular A(2B) receptors, they mediate different changes of some parameters. When evaluating the data obtained by the use of radiolabelled ligands, one has to take into consideration the possible physiological effects of the ligands besides its binding properties to tissues.
authors.affiliation: Department of Biophysics and Cell Biology, University of Debrecen, Hungary.
authors.forename: Bálint
authors.initials: B
authors.lastname: Rubovszky
authors.forename: A József
authors.initials: AJ
authors.lastname: Szentmiklósi
authors.forename: Teréz
authors.initials: T
authors.lastname: Márián
authors.forename: Agnes
authors.initials: A
authors.lastname: Cseppento
authors.forename: Rudolf
authors.initials: R
authors.lastname: Gesztelyi
authors.forename: Andrea
authors.initials: A
authors.lastname: Székely
authors.forename: Fruzsina
authors.initials: F
authors.lastname: Fórizs
authors.forename: Rezso
authors.initials: R
authors.lastname: Gáspár
authors.forename: Lajos
authors.initials: L
authors.lastname: Trón
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Krasznai
mesh_terms: D058908:Adenosine A2 Receptor Agonists; D019830:Adenosine-5'-(N-ethylcarboxamide) / Q000378:metabolism* / Q000494:pharmacology*; D000818:Animals; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D005461:Fluorine / Q000378:metabolism*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects / Q000502:physiology; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D011651:Pulmonary Artery / Q000187:drug effects / Q000502:physiology; D043683:Receptors, Adenosine A2 / Q000502:physiology*
chemical_list: D058908:Adenosine A2 Receptor Agonists; D043683:Receptors, Adenosine A2; D005461:Fluorine; D019830:Adenosine-5'-(N-ethylcarboxamide)